Author:
Millet Aurélien,Pescarmona Rémi,Belot Alexandre,Machon Christelle,Jamilloux Yvan,Guitton Jérôme
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference35 articles.
1. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders;Church;Curr. Opin. Mol. Ther.,2009
2. The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature;Kacar;J. Inflamm. Res.,2020
3. Interleukin-1 Beta-A Friend or Foe in Malignancies?;Bent;Int. J. Mol. Sci.,2018
4. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody;Chakraborty;Clin. Pharmacokinet.,2012
5. Paediatric Rheumatology International Clinical Trials Organisation, A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features;Ruperto;Arthritis Rheum.,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献